CA3125323A1 - Antibacterial composition against drug-resistant bacteria or pro-inflammatory bacteria - Google Patents

Antibacterial composition against drug-resistant bacteria or pro-inflammatory bacteria Download PDF

Info

Publication number
CA3125323A1
CA3125323A1 CA3125323A CA3125323A CA3125323A1 CA 3125323 A1 CA3125323 A1 CA 3125323A1 CA 3125323 A CA3125323 A CA 3125323A CA 3125323 A CA3125323 A CA 3125323A CA 3125323 A1 CA3125323 A1 CA 3125323A1
Authority
CA
Canada
Prior art keywords
bacteria
base sequence
intestinal
bacterium
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3125323A
Other languages
English (en)
French (fr)
Inventor
Kenya Honda
Keiko Yasuma
Koji Atarashi
Seiko Narushima
Munehiro FURUICHI
Takaaki Kawaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Keio University
Original Assignee
Keio University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keio University filed Critical Keio University
Publication of CA3125323A1 publication Critical patent/CA3125323A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3125323A 2019-03-07 2020-03-05 Antibacterial composition against drug-resistant bacteria or pro-inflammatory bacteria Pending CA3125323A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962815101P 2019-03-07 2019-03-07
US62/815,101 2019-03-07
PCT/JP2020/009423 WO2020179868A1 (ja) 2019-03-07 2020-03-05 薬剤耐性細菌又は炎症惹起性細菌に対する抗菌組成物

Publications (1)

Publication Number Publication Date
CA3125323A1 true CA3125323A1 (en) 2020-09-10

Family

ID=72338206

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3125323A Pending CA3125323A1 (en) 2019-03-07 2020-03-05 Antibacterial composition against drug-resistant bacteria or pro-inflammatory bacteria

Country Status (8)

Country Link
US (2) US20220125858A1 (https=)
EP (1) EP3957367B1 (https=)
JP (1) JP7488581B2 (https=)
CN (1) CN113573780B (https=)
AU (1) AU2020232066B2 (https=)
CA (1) CA3125323A1 (https=)
TW (1) TWI843817B (https=)
WO (1) WO2020179868A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024185738A1 (https=) * 2023-03-07 2024-09-12
CN118146998B (zh) * 2024-03-14 2024-08-27 广东悦创生物科技有限公司 一株长双歧杆菌长亚种ks1及其在制备抗衰老和助睡眠药品中的应用
CN119842563B (zh) * 2025-03-17 2025-06-06 昆明医科大学第一附属医院(云南省皮肤病医院) 多尔氏菌emf18-06b1d及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368586B1 (en) 1996-01-26 2002-04-09 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
JP5300772B2 (ja) * 2010-03-26 2013-09-25 森永乳業株式会社 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
US9408878B2 (en) * 2010-12-17 2016-08-09 Compagnie Gervais Danone Lactococcus lactis strains for use in improving digestive condition
US12285475B2 (en) 2016-11-01 2025-04-29 Keio University Bacterium capable of inducing TH1 cells
AU2018302641B2 (en) 2017-07-18 2024-12-19 Keio University Anti-bacterial composition against Th1 cell-inducing bacteria
EP3723776A4 (en) * 2017-12-11 2022-07-27 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms

Also Published As

Publication number Publication date
CN113573780B (zh) 2025-05-06
TW202100172A (zh) 2021-01-01
CN113573780A (zh) 2021-10-29
AU2020232066A1 (en) 2021-07-22
EP3957367B1 (en) 2026-01-14
EP3957367A4 (en) 2023-03-22
TWI843817B (zh) 2024-06-01
EP3957367A1 (en) 2022-02-23
US20250249049A1 (en) 2025-08-07
WO2020179868A1 (ja) 2020-09-10
EP3957367C0 (en) 2026-01-14
AU2020232066B2 (en) 2025-05-08
JPWO2020179868A1 (https=) 2020-09-10
US20220125858A1 (en) 2022-04-28
JP7488581B2 (ja) 2024-05-22

Similar Documents

Publication Publication Date Title
US12036249B2 (en) Anti-bacterial composition against TH1 cell-inducing bacteria
Matziouridou et al. iNOS-and NOX1-dependent ROS production maintains bacterial homeostasis in the ileum of mice
US20250249049A1 (en) Antibacterial composition against drug-resistant bacteria or pro-inflammatory bacteria
JP7399400B2 (ja) Paraprevotella属に属する細菌を有効成分として含有する、トリプシン活性を抑制するための組成物
Uljanovas et al. Prevalence, antimicrobial susceptibility and virulence gene profiles of Arcobacter species isolated from human stool samples, foods of animal origin, ready-to-eat salad mixes and environmental water
JP2022133363A (ja) Th1細胞を誘導する細菌
US20230263839A1 (en) Composition for inhibiting trypsin activity containing as active ingredient bacterium belonging to genus paraprevotella
Beneduzi Immunological Mechanisms, Cellular Processes, and Hindgut Interactions in the Development of Liver Abscesses in Cattle: A Molecular and Cellular Analysis
WO2021221110A1 (ja) Th1細胞及び/又はTh17細胞の増殖又は活性化を誘導する小腸内細菌
HK40018045A (en) Anti-bacterial composition against th1 cell-inducing bacteria
Morrissette The gut microbiome as a therapeutic target in systemic disease
Ku et al. Differences in gut microbiome of Korean indigenous calves as driven by bovine rotavirus and bovine coronavirus infection
Chen et al. Gut commensal Parabacteroides goldsteinii protects against Salmonella infection in mice by enhancing innate defense function
JP2022134885A (ja) 高アンモニア血症の治療又は予防用医薬組成物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20240305

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250225

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250225

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250225

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250715

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20251029

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20251218

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20251218

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20251218

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260223

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260223